Expresses the sense of Congress regarding the illegal importation of prescription drugs.
Urges the President to take action to prevent the illegal importation of prescription drugs from Canada or any other foreign country, and the U.S. Trade Representative to act to correct the inequities and discrimination caused by Canada's Patented Medicine Pricing Review Board.
Urges the pharmaceutical industry and the health care community to: (1) begin a nationwide educational awareness program for U.S. consumers regarding the dangers of imported drugs; and (2) work to ensure that all citizens have access to prescription drugs with the same level of safety and efficacy guaranteed under the current system of regulation.
Declares that: (1) it is essential that U.S. patients have access to affordable prescription drugs; and (2) deregulating foreign prices would increase the flow of new drugs to U.S. consumers.
Introduced in House
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line